CK Life Sciences releases 2025 Sustainability Report, introduces low-carbon transition plan and publishes first Scope 3 emissions

Bulletin Express
Apr 17

CK Life Sciences has published its 2025 Sustainability Report, detailing upgraded climate strategy, strengthened ESG governance and new quantitative disclosures.

Key governance moves • The Board retains ultimate oversight, while the Sustainability Committee met twice in 2025 to review policy, targets and performance. • Climate-related risks have been integrated into the enterprise risk management framework; scenario analysis now quantifies potential financial impacts on water and energy costs under net-zero and business-as-usual pathways. • Directors’ remuneration assessments now reference progress against climate metrics.

Decarbonisation roadmap • A company-wide low-carbon transition plan identifies four levers—fuel substitution, resource efficiency, process upgrades and greener supply chain—across nutraceutical, agriculture and salt operations. • Business units have set new targets (base year 2024 unless stated):  – Cheetham aims for a 62% cut in Scope 2 emissions and 65% renewable electricity by 2035;  – Dominion targets 15% reductions in Scope 1+2 emissions and electricity use by 2035;  – Lipa seeks 10% intensity-based GHG and 11% natural-gas intensity reductions by 2032;  – Australian Agribusiness plans 2% electricity-intensity and 10% chemical-washings cuts by 2035.

Emission profile 2025 • Scope 1+2 emissions rose 4% to 49,237 tonnes CO₂e; intensity held at 0.010 tonne per HK$1,000 revenue. • First disclosure of Scope 3 emissions: 164,516 tonnes CO₂e, dominated by purchased goods and services (72%). • Total energy consumption increased 3% to 173.82 million kWh, with natural gas accounting for 46%.

Operational highlights • Regenerative agriculture project completed acquisition of 350,000 hectares in Australia; expected to sequester about one million tonnes CO₂e and generate tradeable Australian Carbon Credit Units. • Lipa opened a probiotic manufacturing facility and became first contract manufacturer to fully implement new TGA probiotic guidelines. • Cheetham converted traditional gas dryers to fluid-bed technology and installed wildlife hydration stations to support local biodiversity. • Vitaquest expanded waste-recycling initiatives, achieving 1,853 tonnes of plastic recovery and launching EV charging on-site.

People and supply chain • 1,521 employees; training coverage rose to 90.2% from 85.7% in 2024. • No work-related fatalities; lost-time injury rate stood at 3.5 per million hours. • Supplier Code of Conduct and modern-slavery controls enforced across a network of 4,953 suppliers, 56.4% located in Australia.

Community investment • Cash and in-kind donations totalled HK$0.62 million, with staff volunteering 56 hours.

The report affirms CK Life Sciences’ commitment to embed climate resilience, responsible innovation and transparent reporting across its diversified life-sciences, nutraceutical and agriculture businesses.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10